STUDY INFORMATION

STUDY CONTEXT: COPD is a major cause of disability, and it's the fourth leading cause of death in the United States. More than 12 million people are currently diagnosed with COPD. Many more people may have the disease and not even know it. COPD develops slowly. Symptoms often worsen over time and can limit your ability to do routine activities. Severe COPD may prevent you from doing even basic activities like walking, cooking, or taking care of yourself.

Most of the time, COPD is diagnosed in middle-aged or older people. The disease isn't passed from person to person—you can't catch it from someone else. COPD has no cure yet, and doctors don't know how to reverse the damage to the airways and lungs. However, treatments and lifestyle changes can help you feel better, stay more active, and slow the progress of the disease.

-Taken from National Heart Lung and Blood Institute

STUDY PURPOSE:To further evaluate the safety, tolerability and effectiveness of a combination medication for the treatment of moderate COPD in patients who present with cardiovascular risks.

STUDY LENGTH: Up to 3 or 4 years with required study visits every 3 months to our Watt Avenue study center.

COMPENSATION: Yes, enrolled patients will receive payment for travel costs.

PLACEBO GROUP: Yes, 1 out of 4 treatments groups will receive a placebo.

INSURANCE RESTRICTIONS: None, uninsured persons are welcome to inquire.